Table 3.
General population | 6.9 to 10% | Bouhassira et al. (2008), Colloca et al. (2017), Attal et al. (2018) |
Central neuropathic pain | ||
Spinal cord injury | 53 to 85% | Burke et al. (2017), Hatch et al. (2018) |
Stroke | 8 to 30% | Delpont et al. (2018) |
Multiple sclerosis | 29% | Foley et al. (2013) |
Peripheral neuropathic pain | ||
Herpes zoster | 5 to 67% | Mallick-Searle et al. (2016), Forbes et al. (2016) |
Postherpetic neuralgiaa | 100% per definition | |
Diabetes mellitus | ~ 20 to 50% | Alleman et al. (2015), Sloan et al. (2018) |
HIV neuropathy | ~ 20% | Ellis et al. (2010) |
Trigeminal neuralgiaa | 100% per definition | |
Post amputation | 60% | Manchikanti and Singh (2004) |
Post-surgical | 10–50% | Borsook et al. (2013) |
Most references are specific systematic literature reviews. Some did include questionnaire-based screening for the assessment of NP or telephone interviews for follow-up. Ellis et al. (2010) is about the CHARTER study, a longitudinal cohort study
aThese diseases are neuropathic pain conditions according to their clinical definition